Histoneâderived antimicrobial peptides have been identified in various organisms from plants to humans. The rat histoneâH4 mRNA variants, H4âv.1 and rat histogranin (HNr) mRNAs, were recently reported to be involved in the synthesis of H4â(86â100) and its related peptide HNr, respectively. Herein, the two peptides were investigated for putative antimicrobial activity and found to inhibit growth of Gramânegative (Escherichiaâcoli, Pseudomonasâaeruginosa) and Gramâpositive (Bacillusâsubtilis, Staphylococcusâaureus) bacteria. Their inhibitory potencies in E.âcoli (LD50: 3.48 and 4.34âÎŒg·mLâ1) are comparable to that of the antimicrobial peptide LLâ37 (LD50: 4.10âÎŒg·mLâ1). The antimicrobial activities of H4â(86â100) and HNr depend upon the integrity of the molecules, as precursors [H4â(84â102), proâHNr] and fragments [bovine histogranin (HNb)â(1â13), HNbâ(3â13), H4â(89â102) or OGP] are at least five times less potent than the parent peptides. Among various HNâlike compounds, cycloâ(âGlyâpClâPheâTyrâdâArg) (compoundâ3) and Nâ5âguanidino pentanamideâ(2R)âylâ2âNâ(pâhydroxyphenylacetyl)â4â(pâchlorobenzoyl)âphenylene diamine (compoundâ8) display antimicrobial activities comparable to that of HNr. Interestingly, the antimicrobial activities of H4â(86â100), HNr and compoundâ3, like those of quinolone antibiotics acting as DNA gyrase poisons, are potentiated by ATP (1âmm) and coumermycinâA1 (a DNA gyraseâlinked ATPase inhibitor) and blocked by 2,4âdinitrophenol (DNP, an uncoupler of oxidative phosphorylation) and fluoroacetic acid (a metabolic poison). Finally, inâvitro experiments indicate that H4â(86â100), HNr, compoundâ3 and compoundâ8, but not HNbâ(1â13) or HNbâ(3â13), inhibit DNA gyraseâmediated supercoiling of pBR322 DNA. These data indicate that the naturally occurring H4â(86â100) and HNr display antimicrobial effects that involve a modulation of ATPâdependent DNA gyrase.